Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called 'metastatic'. New lung cancer treatments are being developed that directly target the gene mutations...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Livre numérique |
| Idioma: | Anglais |
| Publicat: |
Basel :
S. Karger
2023.
Basel : |
| Accés en línia: | Accès Université d'Orléans et IFPM |
| Nota: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
| Sumari: | Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called 'metastatic'. New lung cancer treatments are being developed that directly target the gene mutations that control how cancers grow and spread. The most important gene mutations in cancer are called 'driver mutations'. In NSCLC, this includes KRAS mutations, which can be used as targets for treatment. There are new treatments designed for lung cancers with a KRAS mutation that are already available. And more are being developed. Treatments in development are tested in clinical trials. There are several different phases of clinical trials that people with cancer can take part in. This booklet aims to help patients with NSCLC understand their options so that they can talk to their doctors, nurses, and medical team about their cancer and its treatment |
|---|---|
| Descripció de l’ítem: | Karger Fast Facts |
| ISBN: | 9783318072778 |
| Accés: | Accès libre pour tout établissement ou utilisateur ayant un compte sur la plateforme de l'éditeur |